Sign In
Get Clay Free →

Suggestions

    Dan Bright

    Director Of Manufacturing Operations at Cellectis

    Professional Background

    Dan Bright is a highly proficient Director of Operations specializing in the rapidly evolving field of Cell and Gene Therapy. With an impressive focus on Operations and Project Management, he has overseen clinical manufacturing and guided technology transfers across a diverse range of therapeutic avenues, such as Autologous and Allogeneic therapies, including the cutting-edge CAR-T and CRISPR technologies. Dan has demonstrated a consistent ability to lead and manage multi-functional teams, whether they are large or small, with a strong emphasis on operational strategy development and change management. His commitment to quality improvement is notable, as he continuously advances projects with an operational excellence mindset.

    Overview of Career

    Beginning his journey in the world of project management and operations, Dan Bright has built an extensive portfolio of experiences that have prepared him for leadership roles within the biotechnology sector. As the Director of Manufacturing Operations at Cellectis, he plays a vital role in steering the company's operational strategies, ensuring not only efficiency but also adherence to regulatory standards that are crucial in clinical settings. His prior experience in previous roles, such as Director of Operations and Senior Project Manager at Hitachi Chemical Advanced Therapeutics Solutions, showcases his progressive career trajectory and deep expertise in the field.

    Education and Achievements

    Dan attained his Bachelor’s Degree in Business with a concentration in Professional Sales from William Paterson University of New Jersey. This educational foundation, paired with his extensive hands-on experience, has equipped him with the strategic thinking and leadership acumen necessary to excel in the complex environment of biotechnology. His studies laid the groundwork for his understanding of market dynamics and the demand for strategic operational decisions within biotech firms.

    Career Progression

    Dan's professional journey reflects his dedication to continuous growth and leadership within the industry. His career began at P.E. Schmitt Co. as an IT Manager and Manufacturer's Representative, where he honed his skills in product development and client interactions. He quickly moved up the ranks at Reed-Lane, from Project Manager to Project/Account Manager, showcasing his ability to handle multifaceted projects from conception to completion.

    His advancement continued at Hitachi Chemical Advanced Therapeutics Solutions, where he transitioned from Senior Project Manager to Director of Operations, demonstrating a strong capacity for both operational management and strategic oversight. His role required him to implement innovative solutions in clinical manufacturing, ultimately contributing to the development and delivery of groundbreaking therapies in gene and cell treatment.

    Notable Achievements

    A notable highlight of Dan's career is his successful leadership in various significant projects focused on advancing Autologous and Allogeneic therapies. In particular, his experience in managing technology transfers has been crucial in the production of CAR-T therapies. He has been instrumental in establishing efficient protocols and processes that align with stringent regulatory requirements. His proactive approach to change management has fostered environments where team members are encouraged to innovate, ensuring constant improvement in operational practices. Dan's expertise in nurturing small and large teams allows him to maintain high morale and productivity levels, integral components for success in fast-paced biopharmaceutical settings.

    In addition to his leadership at Cellectis and Hitachi Chemical Advanced Therapeutics Solutions, Dan has held various positions that showcase his versatile skill set. As the President of Kings Seat Design LLC, he exercised his entrepreneurial spirit and management capabilities. His foundational roles as an Integration Consultant at KTFC Home Theater further established his expertise across different market segments and diversified his knowledge base.

    With a rich and enriching career, Dan Bright stands as a valued leader in the field of Operations within the biotechnology industry, focused particularly on Cell and Gene Therapy companies. His primary objective has always been to drive change, foster improvement, and contribute significantly to the advancement of technologies that can change lives, underlining his commitment to quality care and innovative solutions in therapeutic development.

    Related Questions

    How did Dan Bright's education at William Paterson University of New Jersey prepare him for his career in biotechnology?
    What specific achievements has Dan Bright accomplished in his role as Director of Operations at Cellectis?
    Can Dan Bright share insights about the challenges of managing technology transfers for CAR-T therapies?
    How does Dan Bright approach change management within multi-functional teams in the biotechnology industry?
    What strategies has Dan Bright developed for improving clinical manufacturing processes?
    Dan Bright
    Add to my network

    Location

    New York City Metropolitan Area